Opentrons Labworks, a laboratory robotics firm enabling AI-driven autonomous science, is accelerating the event and deployment of bodily AI-enabled laboratory robotics with Nvidia.
By means of this integration, Opentrons is utilizing Nvidia Isaac and Nvidia Cosmos platforms to develop coaching knowledge for bodily AI fashions purpose-built for laboratory environments.
Opentrons delivers a singular set of real-world property, together with a world fleet of greater than 10,000 deployed robotic techniques throughout main analysis universities and biopharma corporations, in addition to deep experimental experience spanning each Opentrons platforms and a variety of third-party laboratory devices.
Opentrons, with Nvidia, is bridging simulation and actuality to carry bodily AI into on a regular basis laboratory workflows.
BioNeMo offers the muse for coaching and deploying AI fashions for organic discovery, whereas Opentrons provides the standardized bodily execution layer required to shut the loop between digital design and experimental validation.
Till now, AI in drug discovery has largely been constrained to prediction: proposing molecular constructions, suggesting targets, and analyzing datasets.
Experimental execution now represents the bottleneck to novel discoveries. By standardizing experimental execution and producing high-quality coaching knowledge from actual laboratory operations, Opentrons allows AI techniques to constantly study from wet-lab outcomes.
James Atwood, CEO of Opentrons, says: “We see a future the place bodily AI unlocks autonomous experimental execution all through laboratory environments.
“AI fashions and brokers suggest a speculation and experimental plan; our techniques execute that experiment. The outcomes are then fed again to the AI in a closed loop to refine the experiment additional. When that cycle runs constantly throughout 1000’s of labs, discovery timelines compress from years to weeks.”
“Connecting computational fashions with experimental validation is important to accelerating AI-driven drug discovery,” mentioned Stacie Calad-Thomson, North American enterprise growth lead for healthcare and life sciences at Nvidia.
“With Nvidia AI, Opentrons offers the standardized bodily infrastructure that turns experimental designs into constant, reproducible outcomes – serving to generate the coaching knowledge wanted to develop bodily AI fashions that may function throughout various laboratory environments.”
Opentrons builds AI-enabled laboratory robots that automate experimental execution throughout workflows starting from antibody discovery to proteomics and genomics.
With techniques deployed throughout each top-20 US analysis college and 14 of the highest 15 world biopharma corporations, Opentrons operates the world’s largest standardized community of lab automation.
Opentrons and Nvidia will current the partnership on the SLAS International Conference and Exhibition, February Sep 11, 2026, in Boston.
The joint session, “Opentrons x Nvidia: Extending Lab Automation into the Period of Bodily AI”, will discover how AI-driven planning and robotic execution are converging to allow techniques that design, run, and study from their very own experiments.
Instantly after the speak, Nvidia representatives will be part of Opentrons at sales space #917 to reply any attendee questions, with alternatives for scientists to join a brand new program enabling the contribution of actual experimental execution knowledge to the coaching of AI techniques for science.
